Retinoblastoma

David M. Gamm, Amol D. Kulkarni, Daniel Albert

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Retinoblastoma is the most common and important malignant eye tumor of childhood, and after malignant melanoma it is the most common primary intraocular malignancy of the eye. This tumor was established as an entity by the Scotsman James Wardrop (1782-1869) in his Observations on the Fungus Haematodes. Wardrop appreciated that the tumor originated in the retina, and he was the first to advocate early enucleation in its treatment (12). The tumor, although accounting for only approximately 1% of deaths from cancer under 15 years of age (85), has attracted wide interest from a variety of disciplines, including epidemiology, genetics, and molecular biology. The seminal observation that retinoblastoma arises in susceptible developing retinal cells when both alleles of the retinoblastoma gene (RB1) are mutated, and the isolation and cloning of RB1 gene (56,115,124), have established this tumor as a model of oncogenesis. The literature on the tumor and the causative gene has grown dramatically. These advances have been accompanied by a more complete understanding of the histogenesis, growth, and differentiation of the tumor (219), as well as a more complete elucidation of its molecular genetics (21). Improvement in the treatment of retinoblastoma has led to reports of 5-year survival rates of 90% and 98% in Europe and the United States, respectively (255,300).

Original languageEnglish (US)
Title of host publicationGarner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition
PublisherCRC Press
Pages1299-1326
Number of pages28
ISBN (Electronic)9781420093919
ISBN (Print)142007976X, 9781420079760
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Retinoblastoma
Neoplasms
Molecular Biology
Retinoblastoma Genes
Molecular Epidemiology
Genes
Retina
Organism Cloning
Melanoma
Carcinogenesis
Fungi
Alleles
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gamm, D. M., Kulkarni, A. D., & Albert, D. (2007). Retinoblastoma. In Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition (pp. 1299-1326). CRC Press.

Retinoblastoma. / Gamm, David M.; Kulkarni, Amol D.; Albert, Daniel.

Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, 2007. p. 1299-1326.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gamm, DM, Kulkarni, AD & Albert, D 2007, Retinoblastoma. in Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, pp. 1299-1326.
Gamm DM, Kulkarni AD, Albert D. Retinoblastoma. In Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press. 2007. p. 1299-1326
Gamm, David M. ; Kulkarni, Amol D. ; Albert, Daniel. / Retinoblastoma. Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, 2007. pp. 1299-1326
@inbook{14ab101462214aca814d5f99ee9e9750,
title = "Retinoblastoma",
abstract = "Retinoblastoma is the most common and important malignant eye tumor of childhood, and after malignant melanoma it is the most common primary intraocular malignancy of the eye. This tumor was established as an entity by the Scotsman James Wardrop (1782-1869) in his Observations on the Fungus Haematodes. Wardrop appreciated that the tumor originated in the retina, and he was the first to advocate early enucleation in its treatment (12). The tumor, although accounting for only approximately 1{\%} of deaths from cancer under 15 years of age (85), has attracted wide interest from a variety of disciplines, including epidemiology, genetics, and molecular biology. The seminal observation that retinoblastoma arises in susceptible developing retinal cells when both alleles of the retinoblastoma gene (RB1) are mutated, and the isolation and cloning of RB1 gene (56,115,124), have established this tumor as a model of oncogenesis. The literature on the tumor and the causative gene has grown dramatically. These advances have been accompanied by a more complete understanding of the histogenesis, growth, and differentiation of the tumor (219), as well as a more complete elucidation of its molecular genetics (21). Improvement in the treatment of retinoblastoma has led to reports of 5-year survival rates of 90{\%} and 98{\%} in Europe and the United States, respectively (255,300).",
author = "Gamm, {David M.} and Kulkarni, {Amol D.} and Daniel Albert",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "142007976X",
pages = "1299--1326",
booktitle = "Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition",
publisher = "CRC Press",

}

TY - CHAP

T1 - Retinoblastoma

AU - Gamm, David M.

AU - Kulkarni, Amol D.

AU - Albert, Daniel

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Retinoblastoma is the most common and important malignant eye tumor of childhood, and after malignant melanoma it is the most common primary intraocular malignancy of the eye. This tumor was established as an entity by the Scotsman James Wardrop (1782-1869) in his Observations on the Fungus Haematodes. Wardrop appreciated that the tumor originated in the retina, and he was the first to advocate early enucleation in its treatment (12). The tumor, although accounting for only approximately 1% of deaths from cancer under 15 years of age (85), has attracted wide interest from a variety of disciplines, including epidemiology, genetics, and molecular biology. The seminal observation that retinoblastoma arises in susceptible developing retinal cells when both alleles of the retinoblastoma gene (RB1) are mutated, and the isolation and cloning of RB1 gene (56,115,124), have established this tumor as a model of oncogenesis. The literature on the tumor and the causative gene has grown dramatically. These advances have been accompanied by a more complete understanding of the histogenesis, growth, and differentiation of the tumor (219), as well as a more complete elucidation of its molecular genetics (21). Improvement in the treatment of retinoblastoma has led to reports of 5-year survival rates of 90% and 98% in Europe and the United States, respectively (255,300).

AB - Retinoblastoma is the most common and important malignant eye tumor of childhood, and after malignant melanoma it is the most common primary intraocular malignancy of the eye. This tumor was established as an entity by the Scotsman James Wardrop (1782-1869) in his Observations on the Fungus Haematodes. Wardrop appreciated that the tumor originated in the retina, and he was the first to advocate early enucleation in its treatment (12). The tumor, although accounting for only approximately 1% of deaths from cancer under 15 years of age (85), has attracted wide interest from a variety of disciplines, including epidemiology, genetics, and molecular biology. The seminal observation that retinoblastoma arises in susceptible developing retinal cells when both alleles of the retinoblastoma gene (RB1) are mutated, and the isolation and cloning of RB1 gene (56,115,124), have established this tumor as a model of oncogenesis. The literature on the tumor and the causative gene has grown dramatically. These advances have been accompanied by a more complete understanding of the histogenesis, growth, and differentiation of the tumor (219), as well as a more complete elucidation of its molecular genetics (21). Improvement in the treatment of retinoblastoma has led to reports of 5-year survival rates of 90% and 98% in Europe and the United States, respectively (255,300).

UR - http://www.scopus.com/inward/record.url?scp=85057939252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057939252&partnerID=8YFLogxK

M3 - Chapter

SN - 142007976X

SN - 9781420079760

SP - 1299

EP - 1326

BT - Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition

PB - CRC Press

ER -